TrialHepatology communications2022

Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab-based model.

Anahita Rabiee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.